Cargando…

Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review

BACKGROUND AND OBJECTIVES: There is currently no consensus about the extent of gray matter (GM) atrophy that can be attributed to secondary changes after white matter (WM) lesions or the temporal and spatial relationships between the 2 phenomena. Elucidating this interplay will broaden the understan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lie, Ingrid Anne, Weeda, Merlin M., Mattiesing, Rozemarijn M., Mol, Marijke A.E., Pouwels, Petra J.W., Barkhof, Frederik, Torkildsen, Øivind, Bø, Lars, Myhr, Kjell-Morten, Vrenken, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038199/ https://www.ncbi.nlm.nih.gov/pubmed/35173016 http://dx.doi.org/10.1212/WNL.0000000000200006

Ejemplares similares

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model
por: Fjær, Sveinung, et al.
Publicado: (2013)

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis
por: Mattiesing, Rozemarijn M., et al.
Publicado: (2022)

Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis
por: Weeda, Merlin M., et al.
Publicado: (2020)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
por: Pelkmans, Wiesje, et al.
Publicado: (2019)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017)

Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs)()
por: Steenwijk, Martijn D., et al.
Publicado: (2013)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study
por: Möller, Christiane, et al.
Publicado: (2015)

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
por: Holmøy, Trygve, et al.
Publicado: (2020)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities
por: Duan, Dazhi, et al.
Publicado: (2016)

Atrophy in subcortical gray matter in adult patients with moyamoya disease
por: Zuo, Zhiwei, et al.
Publicado: (2023)

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model
por: Wergeland, Stig, et al.
Publicado: (2011)

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)

The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study
por: Gentile, Giordano, et al.
Publicado: (2023)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

Gray matter atrophy rate as a marker of disease progression in AD
por: Anderson, Valerie M., et al.
Publicado: (2012)

The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis
por: Dupuy, Sheena L., et al.
Publicado: (2016)

Patterns of Cerebellar Gray Matter Atrophy Across Alzheimer’s Disease Progression
por: Toniolo, Sofia, et al.
Publicado: (2018)

Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
por: Kincses, Bálint, et al.
Publicado: (2019)

Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization
por: De Stefano, Nicola, et al.
Publicado: (2021)

Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
por: Bussas, Matthias, et al.
Publicado: (2021)

Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis
por: Lin, Aiyu, et al.
Publicado: (2013)

Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy
por: Lin, Junyu, et al.
Publicado: (2020)

Brain Gray Matter Atrophy and Functional Connectivity Remodeling in Patients With Chronic LHON
por: Tian, Qin, et al.
Publicado: (2022)

White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants
por: Brugulat‐Serrat, Anna, et al.
Publicado: (2019)

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
por: Amiri, Houshang, et al.
Publicado: (2018)

Progression of regional grey matter atrophy in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
por: Riemer, Frank, et al.
Publicado: (2023)

Gray matter alterations and correlation of nutritional intake with the gray matter volume in prediabetes
por: Hou, Yi-Cheng, et al.
Publicado: (2016)

Deep gray matter volume loss drives disability worsening in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Global gray matter changes in posterior cortical atrophy: A serial imaging study
por: Lehmann, Manja, et al.
Publicado: (2012)

Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis
por: Yu, Fang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nghg3ukg77bt9jiou9fsim625d